Нарушения мочеиспускания, дефекации и половой функции при рассеянном склерозе
Слабость и спастичность при рассеянном склерозе
ИзмененияСМЖпри рассеянном склерозе
Caroscio, J. T., et al. Quantitative CSF IgG measurements in multiple sclerosis and other neurological diseases: An update. Arch. Neurol. 40:409, 1983.
Farlow, M. R., et al. Multiple sclerosis: Magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis. Neurology (Minneapolis), 36:828, 1986.
Farrell, M. A., et al. Oligoclonal bands in multiple sclerosis: Clinical-pathologic correlation. Neurology (Minneapolis) 35:212, 1985.
Gerson, B., et al. Myelin basic protein, oligoclonal bands, and IgG in cerebrospinal fluid as indicators of multiple sclerosis. Clin. Chem. 27:1974, 1981.
Johnson, K. P. Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis, Neurology (Minneapolis) 3:106, 1980.
Schapira, K. Is lumbar puncture harmful in multiple sclerosis? J. Neurol. Neurosurg. Psychiatry 22:238, 1959.
Coffey, R. J., et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J. Neurosurgery 78:226, 1993.
Duncan, G. W., Shahani, B. T., and Young, R. R. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. Neurology (Minneapolis) 26:441, 1976.
Gelenberg, A. J., and Poskanzer, D. C. The effects of dantrolene sodium on spasticity in multiple sclerosis. Neurology (Minneapolis) 23:1313, 1973.
Lenman, J. A. R. A clinical and experimental study of the effects of exercise on motor weakness in neurological disease. J. Neurol. Neurosurg. Psychiatry 22:182, 1959.
Levine, I., et al. Diazepam in the treatment of spasticity: A preliminary quantitative evaluation. J. Chronic Dis. 22:57, 1969.
Liversedge, L. A., and Maher, R. M. Use of phenol in relief of spasticity. Br. Med. J. 2:31, 1960.
Selker, R., Greenberg, A., and Marshall, M. Anterior rhizotomy for flexor spasms and contractures of the legs secondary to multiple sclerosis. Ann. Surg. 162:298, 1965.
Betts, C. D., Dmellow, M. T., and Fowler, C. J. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 56:245, 1993.
Blaivas, J. G. Management of bladder dysfunction in multiple sclerosis. Neurology (Minneapolis) 30:12, 1980.
Massey, E. W., and Pleet, A. Penile prosthesis for impotence in multiple sclerosis. Ann. Neurol. 6:451, 1979.
Peterson, T., and Pedersen, E. Neurodynamic evaluation of voiding dysfunction in multiple sclerosis. Acta Neurol. Scand. 69:402, 1984.
Tarabulcy, E. Bladder disturbances in multiple sclerosis and their management. Mod. Treat. 7:941, 1970.
Vas, C. J. Sexual impotence and some autonomic disturbances in men with multiple sclerosis. Acta Neurol. Scand. 45:166, 1969.
Beatly, W. W., et al. Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. Arch. Neurol. 45:611, 1988.
Krupp, L. B., et al. Fatigue in multiple sclerosis. Arch. Neurol. 45:435, 1988.
Peyser, J. M., et al. Cognitive function in patients with multiple sclerosis. Arch. Neurol. 37:577, 1980.
Rosenberg, G. A., and Appenzeller, O. Amantadine, fatigue, and multiple sclerosis. Arch. Neurol. 45:1104, 1988.
Schiffer, R. B. The spectrum of depression in multiple sclerosis. Arch. Neurol. 44:596, 1987.
Weinshenker, B. G., et al. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 42:1468, 1992.